Immunomodulation for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury or Disease During Primary In-House Rehabilitation: Results From a Randomized Placebo-Controlled Feasibility Trial (UroVaxom-Pilot)
The trial demonstrated strong retention and adherence rates with minimal participant burden. Consideration of broader inclusion criteria is suggested to improve the number of eligible patients and enhance participant recruitment.
Authors
- Julia Neuenschwander (ORCID: https://orcid.org/0000-0003-2853-6280)
- Ezra Valido
- Jivko Stoyanov (ORCID: https://orcid.org/0000-0001-6842-6284)
- J. Pannek
- Jörg Krebs (ORCID: https://orcid.org/0000-0003-1807-2670)
- Jens Wöllner (ORCID: https://orcid.org/0000-0002-2518-8738)
- Michael Harder
- J Mahler (ORCID: https://orcid.org/0009-0002-7153-6016)
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
- Swiss Paraplegic Center (CH)
- Institute of Social and Preventive Medicine (CH)
- Swiss Paraplegic Research (CH)
Publication Details
- Journal
- Topics in Spinal Cord Injury Rehabilitation
- Published
- 2025-04-30
- DOI
- https://doi.org/10.46292/sci24-00045
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.84